All News #Library
Rare Diseases
Biodexa Licenses P 1 Drug Candidate from Otsuka for Rare Cancer
20 Feb 2026 //
PHARMIWEB
Dawnzera Receives EU Approval For Hereditary Angioedema
22 Jan 2026 //
PHARMIWEB
European Union Approves DAWNZERA For Hereditary Angioedema
21 Jan 2026 //
BUSINESSWIRE
Otsuka pays Ionis $65M for European rights to rare disease drug
19 Dec 2023 //
FIERCE BIOTECH
Otsuka, Missy Franklin team up for rare kidney disease campaign
03 Nov 2023 //
FIERCE PHARMA

Market Place
Sourcing Support